Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis
S Wang, H Geng, Y Li, Z Xu, K Yang, L Yang, F Hui… - Heliyon, 2024 - cell.com
Background Transarterial chemoembolization (TACE) is a common treatment for
hepatocellular carcinoma (HCC), but the best therapeutic agent for TACE treatment has not …
hepatocellular carcinoma (HCC), but the best therapeutic agent for TACE treatment has not …
A novel neutrophil-to-lymphocyte ratio and sarcopenia based TACE-predict model of hepatocellular carcinoma patients
S Wang, X Zhang, Q Chen, ZC Jin, J Lu… - Journal of …, 2023 - Taylor & Francis
Purpose Transarterial chemoembolization (TACE) was commonly applied in hepatocellular
carcinoma (HCC) patients across BCLC AC stages with heterogeneous outcomes in real …
carcinoma (HCC) patients across BCLC AC stages with heterogeneous outcomes in real …
Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis
D Li, X Zhao, X Pi, K Wang, D Song - Clinical and experimental medicine, 2023 - Springer
The systemic immune-inflammation index (SII), derived from neutrophil, platelet, and
lymphocyte counts, has been associated with prognosis of patients with cancer. We …
lymphocyte counts, has been associated with prognosis of patients with cancer. We …
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative …
BL Zhang, J Liu, G Diao, J Chang, J Xue… - Journal of …, 2024 - Taylor & Francis
Purpose We developed a nomogram based on the liver function, nutrition, inflammation, and
immunity (LFNII) score to predict recurrence-free survival (RFS) post-resection in patients …
immunity (LFNII) score to predict recurrence-free survival (RFS) post-resection in patients …
Systemic Inflammation-Based Staging System for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization: A Multicenter Study
K Ji, J Niu, C Zhang, Y Shi, Z Liang, Z Wang, T Xu… - Academic …, 2024 - Elsevier
Rationale and Objectives The optimal prognostic assessment for patients with
hepatocellular carcinoma (HCC) after drug-eluting bead transarterial chemoembolization …
hepatocellular carcinoma (HCC) after drug-eluting bead transarterial chemoembolization …
Machine Learning Models in Prediction of Treatment Response After Chemoembolization with MRI Clinicoradiomics Features
Purpose To evaluate machine learning models, created with radiomics and clinicoradiomics
features, ability to predict local response after TACE. Materials and Methods 188 treatment …
features, ability to predict local response after TACE. Materials and Methods 188 treatment …
Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial …
D Zhao, W Xu, Y Zhan, L Xu, W Ding… - Clinical Medicine …, 2023 - journals.sagepub.com
Background: Recent studies have shown that inflammatory indicators are closely related to
the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful …
the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful …
Which Agent is the Best Tace Agent for Patients with Different Nlr Hepatocellular Carcinomas? A Systematic Review and Network Meta-Analysis
S Wang, H Geng, Y Li, K Yang, L Yang, Q Zhao… - A Systematic Review … - papers.ssrn.com
Background Transarterial chemoembolization (TACE) is a common treatment for
Hepatocellular carcinoma (HCC), but the most optimal therapeutic agent for TACE treatment …
Hepatocellular carcinoma (HCC), but the most optimal therapeutic agent for TACE treatment …
[PDF][PDF] HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization
F Pelizzaro - … ASSOCIATED WITH PROGNOSIS IN PATIENTS WITH … - research.unipd.it
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with
transarterial chemoembolization Page 143 143 CHAPTER 6 HIF-1α and VEGF as prognostic …
transarterial chemoembolization Page 143 143 CHAPTER 6 HIF-1α and VEGF as prognostic …